0

Close
 
Upcoming Allied Market Research
2023
Pharmaceutical Equipment Testing Market

Pharmaceutical Equipment Testing Market

by Equipment (Gas Permeation Tester, Container Gas Permeability Tester, Permeability Analyser, Gas Transmission Rate Instrument, Others), by Service (Container Testing, Container Closure Integrity Testing, Life Testing, Visual Inspection, Functional Testing, Stability Testing, Batch-Release Testing, Others) and by End User (Pharmaceutical Companies, Contract Research Organizations, Government Organization, Research Institutes, Testing Laboratories): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals
Report Code: A13221
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Pharmaceutical Equipment Testing Market

Request Now !

Pharmaceutical Equipment Testing Market Overview 2030

Pharmaceutical equipment consist of medical equipment which ranging from pharmaceutical machinery, medical instruments, and devices used in healthcare sector. This pharmaceutical equipment are used in manufacturing and processing of pharmaceutical drugs which are used in diagnosis, treatment, and analysis of medical conditions. Pharmaceutical equipment are tested time to time to check quality and performance of this equipment. Equipment testing such as texture analyzer, vibration tester, moisture meter, functional testing, and package drop tester among others are the testing types of pharmaceutical testing. This testing ensures error free functionality, accuracy, and quality of the pharmaceutical equipment.

COVID-19 Impact Analysis             

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Coronavirus disease 2019 (COVID-19) has created an economic crisis in addition to the healthcare crisis. COVID-19 pandemic has stretched healthcare system worldwide; developed countries are expected to cause economic recession. The pandemic has an adverse impact on the healthcare system, resulting in 50% to 70% drop in revenue from March. Many small hospitals, clinics, and nursing homes, have been forced to shut their operations. In addition, social distancing and localized curfews have resulted in delayed elective surgical procedures. Further, visa cancellations have led to an interruption in medical tourism and can negatively impact the healthcare services market growth.

Top Impacting Factors

  • Surge in requirement of modern pharmaceutical manufacturing machinery, increase in launch of advance manufacturing facilities, rise in demand for modern pharmaceutical equipment, surge in usage of accurate testing services, and increase in focus on regulations regarding assurance are the key factors that drive the growth of pharmaceutical equipment testing market.
  • In addition, increase in adoption of advance healthcare services, rise in rate of innovation in pharmaceutical industry, rise concerns about safety & quality of drugs, increase in number of end users, surge in R & D activities to improve efficiency of pharmaceutical equipment, rise in investment on healthcare sector and increase in demand for specific types of equipment test are some factors that fuel the growth of pharmaceutical equipment testing market.
  • However, high cost associated with equipment testing hinder the growth of market.
  • Contrarily, rise in development in pharmaceutical manufacturing machinery and benefits associated with testing of equipment are expected to offer lucrative opportunities for the expansion of the market.

Market Trend

Business Expansion Strategies by Key Market Players

In 2019, Intertek Group Plc announced the expansion of their pharmaceutical equipment testing services in Milbourn. This new testing service help pharmaceutical companies for audit of their pharmaceutical equipment to boost their manufacturing.

In 2019, Boston Analytical announced opening of new testing service office in Cambridge. This company is based on delivering top notch pharmaceutical equipment testing services to their clients.

Key Benefits of the Report

  • This study presents the analytical depiction of pharmaceutical equipment testing market industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the pharmaceutical equipment testing market share.
  • The current market is quantitatively analyzed to highlight the pharmaceutical equipment testing market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Pharmaceutical Equipment Testing Market Report 

  • Which are the leading players active in the pharmaceutical equipment testing market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is "pharmaceutical equipment testing"?
  • What is "pharmaceutical equipment testing" market prediction in the future?
  • Who are the leading global players in the "pharmaceutical equipment testing" market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "pharmaceutical equipment testing" market report?

 Pharmaceutical Equipment Testing Market Report Highlights

Aspects Details
By Equipment
  • Gas Permeation Tester
  • Container Gas Permeability Tester
  • Permeability Analyser
  • Gas Transmission Rate Instrument
  • Others
By Service
  • Container Testing
  • Container Closure Integrity Testing
  • Life Testing
  • Visual Inspection
  • Functional Testing
  • Stability Testing
  • Batch-Release Testing
  • Others
By End User
  • Pharmaceutical Companies
  • Contract Research Organizations
  • Government Organization
  • Research Institutes
  • Testing Laboratories
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Eurofins ScientificNelson Laboratories, LLC, NSF International, TM Electronics, Inc., Labthink, Edwards Analyticals, Qualitest International, Inc., TEN-E Packaging Services, Inc., Albany Molecular Research, inc., West Pharmaceutical Services, Inc., TASI Group
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: PHARMACEUTICAL EQUIPMENT TESTING MARKET, BY EQUIPMENT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Equipment

    • 4.2. Gas Permeation Tester

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Container Gas Permeability Tester

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Permeability Analyser

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Gas Transmission Rate Instrument

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Others

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: PHARMACEUTICAL EQUIPMENT TESTING MARKET, BY SERVICE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Service

    • 5.2. Container Testing

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Container Closure Integrity Testing

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Life Testing

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Visual Inspection

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Functional Testing

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Stability Testing

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Batch-Release Testing

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

    • 5.9. Others

      • 5.9.1. Key Market Trends, Growth Factors and Opportunities

      • 5.9.2. Market Size and Forecast, By Region

      • 5.9.3. Market Share Analysis, By Country

  • CHAPTER 6: PHARMACEUTICAL EQUIPMENT TESTING MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Pharmaceutical Companies

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Contract Research Organizations

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Government Organization

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Research Institutes

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Testing Laboratories

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

  • CHAPTER 7: PHARMACEUTICAL EQUIPMENT TESTING MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Equipment

      • 7.2.3. Market Size and Forecast, By Service

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Pharmaceutical Equipment Testing Market

        • 7.2.6.1. Market Size and Forecast, By Equipment
        • 7.2.6.2. Market Size and Forecast, By Service
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Pharmaceutical Equipment Testing Market

        • 7.2.7.1. Market Size and Forecast, By Equipment
        • 7.2.7.2. Market Size and Forecast, By Service
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Pharmaceutical Equipment Testing Market

        • 7.2.8.1. Market Size and Forecast, By Equipment
        • 7.2.8.2. Market Size and Forecast, By Service
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Equipment

      • 7.3.3. Market Size and Forecast, By Service

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Pharmaceutical Equipment Testing Market

        • 7.3.6.1. Market Size and Forecast, By Equipment
        • 7.3.6.2. Market Size and Forecast, By Service
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Pharmaceutical Equipment Testing Market

        • 7.3.7.1. Market Size and Forecast, By Equipment
        • 7.3.7.2. Market Size and Forecast, By Service
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Pharmaceutical Equipment Testing Market

        • 7.3.8.1. Market Size and Forecast, By Equipment
        • 7.3.8.2. Market Size and Forecast, By Service
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Pharmaceutical Equipment Testing Market

        • 7.3.9.1. Market Size and Forecast, By Equipment
        • 7.3.9.2. Market Size and Forecast, By Service
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Pharmaceutical Equipment Testing Market

        • 7.3.10.1. Market Size and Forecast, By Equipment
        • 7.3.10.2. Market Size and Forecast, By Service
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Pharmaceutical Equipment Testing Market

        • 7.3.11.1. Market Size and Forecast, By Equipment
        • 7.3.11.2. Market Size and Forecast, By Service
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Pharmaceutical Equipment Testing Market

        • 7.3.12.1. Market Size and Forecast, By Equipment
        • 7.3.12.2. Market Size and Forecast, By Service
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Equipment

      • 7.4.3. Market Size and Forecast, By Service

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Pharmaceutical Equipment Testing Market

        • 7.4.6.1. Market Size and Forecast, By Equipment
        • 7.4.6.2. Market Size and Forecast, By Service
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Pharmaceutical Equipment Testing Market

        • 7.4.7.1. Market Size and Forecast, By Equipment
        • 7.4.7.2. Market Size and Forecast, By Service
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Pharmaceutical Equipment Testing Market

        • 7.4.8.1. Market Size and Forecast, By Equipment
        • 7.4.8.2. Market Size and Forecast, By Service
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Pharmaceutical Equipment Testing Market

        • 7.4.9.1. Market Size and Forecast, By Equipment
        • 7.4.9.2. Market Size and Forecast, By Service
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Pharmaceutical Equipment Testing Market

        • 7.4.10.1. Market Size and Forecast, By Equipment
        • 7.4.10.2. Market Size and Forecast, By Service
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Pharmaceutical Equipment Testing Market

        • 7.4.11.1. Market Size and Forecast, By Equipment
        • 7.4.11.2. Market Size and Forecast, By Service
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Pharmaceutical Equipment Testing Market

        • 7.4.12.1. Market Size and Forecast, By Equipment
        • 7.4.12.2. Market Size and Forecast, By Service
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Pharmaceutical Equipment Testing Market

        • 7.4.13.1. Market Size and Forecast, By Equipment
        • 7.4.13.2. Market Size and Forecast, By Service
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Pharmaceutical Equipment Testing Market

        • 7.4.14.1. Market Size and Forecast, By Equipment
        • 7.4.14.2. Market Size and Forecast, By Service
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Equipment

      • 7.5.3. Market Size and Forecast, By Service

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Pharmaceutical Equipment Testing Market

        • 7.5.6.1. Market Size and Forecast, By Equipment
        • 7.5.6.2. Market Size and Forecast, By Service
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Pharmaceutical Equipment Testing Market

        • 7.5.7.1. Market Size and Forecast, By Equipment
        • 7.5.7.2. Market Size and Forecast, By Service
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Pharmaceutical Equipment Testing Market

        • 7.5.8.1. Market Size and Forecast, By Equipment
        • 7.5.8.2. Market Size and Forecast, By Service
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Pharmaceutical Equipment Testing Market

        • 7.5.9.1. Market Size and Forecast, By Equipment
        • 7.5.9.2. Market Size and Forecast, By Service
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Pharmaceutical Equipment Testing Market

        • 7.5.10.1. Market Size and Forecast, By Equipment
        • 7.5.10.2. Market Size and Forecast, By Service
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Pharmaceutical Equipment Testing Market

        • 7.5.11.1. Market Size and Forecast, By Equipment
        • 7.5.11.2. Market Size and Forecast, By Service
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Labthink

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. TM Electronics, Inc.

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Qualitest International, Inc.

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. TEN-E Packaging Services, Inc.

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Albany Molecular Research, Inc.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. TASI Group

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. West Pharmaceutical Services, Inc.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Edwards Analyticals

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. NSF International

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Eurofins ScientificNelson Laboratories, LLC

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR GAS PERMEATION TESTER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR CONTAINER GAS PERMEABILITY TESTER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR PERMEABILITY ANALYSER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR GAS TRANSMISSION RATE INSTRUMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR CONTAINER TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR CONTAINER CLOSURE INTEGRITY TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR LIFE TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR VISUAL INSPECTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR FUNCTIONAL TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR STABILITY TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR BATCH-RELEASE TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR GOVERNMENT ORGANIZATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR TESTING LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA PHARMACEUTICAL EQUIPMENT TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. U.S. PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 28. U.S. PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 29. U.S. PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. CANADA PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 31. CANADA PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 32. CANADA PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE PHARMACEUTICAL EQUIPMENT TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. FRANCE PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 41. FRANCE PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. GERMANY PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 44. GERMANY PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 45. GERMANY PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. ITALY PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 47. ITALY PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 48. ITALY PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. SPAIN PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 50. SPAIN PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 51. SPAIN PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. UK PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 53. UK PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 54. UK PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. RUSSIA PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 56. RUSSIA PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 57. RUSSIA PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. REST OF EUROPE PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 59. REST OF EUROPE PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 60. REST OF EUROPE PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. ASIA-PACIFIC PHARMACEUTICAL EQUIPMENT TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 62. ASIA-PACIFIC PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 63. ASIA-PACIFIC PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 64. ASIA-PACIFIC PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. CHINA PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 66. CHINA PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 67. CHINA PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. JAPAN PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 69. JAPAN PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 70. JAPAN PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. INDIA PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 72. INDIA PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 73. INDIA PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. SOUTH KOREA PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 75. SOUTH KOREA PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 76. SOUTH KOREA PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. AUSTRALIA PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 78. AUSTRALIA PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 79. AUSTRALIA PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. THAILAND PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 81. THAILAND PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 82. THAILAND PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. MALAYSIA PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 84. MALAYSIA PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 85. MALAYSIA PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. INDONESIA PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 87. INDONESIA PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 88. INDONESIA PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. REST OF ASIA PACIFIC PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 90. REST OF ASIA PACIFIC PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 91. REST OF ASIA PACIFIC PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. LAMEA PHARMACEUTICAL EQUIPMENT TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 93. LAMEA PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 94. LAMEA PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 95. LAMEA PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. BRAZIL PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 97. BRAZIL PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 98. BRAZIL PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 99. SOUTH AFRICA PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 100. SOUTH AFRICA PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 101. SOUTH AFRICA PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 102. SAUDI ARABIA PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 103. SAUDI ARABIA PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 104. SAUDI ARABIA PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 105. UAE PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 106. UAE PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 107. UAE PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. ARGENTINA PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 109. ARGENTINA PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 110. ARGENTINA PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 111. REST OF LAMEA PHARMACEUTICAL EQUIPMENT TESTING, BY EQUIPMENT, 2022-2032 ($MILLION)
  • TABLE 112. REST OF LAMEA PHARMACEUTICAL EQUIPMENT TESTING, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 113. REST OF LAMEA PHARMACEUTICAL EQUIPMENT TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 114. LABTHINK: KEY EXECUTIVES
  • TABLE 115. LABTHINK: COMPANY SNAPSHOT
  • TABLE 116. LABTHINK: OPERATING SEGMENTS
  • TABLE 117. LABTHINK: PRODUCT PORTFOLIO
  • TABLE 118. LABTHINK: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. TM ELECTRONICS, INC.: KEY EXECUTIVES
  • TABLE 120. TM ELECTRONICS, INC.: COMPANY SNAPSHOT
  • TABLE 121. TM ELECTRONICS, INC.: OPERATING SEGMENTS
  • TABLE 122. TM ELECTRONICS, INC.: PRODUCT PORTFOLIO
  • TABLE 123. TM ELECTRONICS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. QUALITEST INTERNATIONAL, INC.: KEY EXECUTIVES
  • TABLE 125. QUALITEST INTERNATIONAL, INC.: COMPANY SNAPSHOT
  • TABLE 126. QUALITEST INTERNATIONAL, INC.: OPERATING SEGMENTS
  • TABLE 127. QUALITEST INTERNATIONAL, INC.: PRODUCT PORTFOLIO
  • TABLE 128. QUALITEST INTERNATIONAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. TEN-E PACKAGING SERVICES, INC.: KEY EXECUTIVES
  • TABLE 130. TEN-E PACKAGING SERVICES, INC.: COMPANY SNAPSHOT
  • TABLE 131. TEN-E PACKAGING SERVICES, INC.: OPERATING SEGMENTS
  • TABLE 132. TEN-E PACKAGING SERVICES, INC.: PRODUCT PORTFOLIO
  • TABLE 133. TEN-E PACKAGING SERVICES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. ALBANY MOLECULAR RESEARCH, INC.: KEY EXECUTIVES
  • TABLE 135. ALBANY MOLECULAR RESEARCH, INC.: COMPANY SNAPSHOT
  • TABLE 136. ALBANY MOLECULAR RESEARCH, INC.: OPERATING SEGMENTS
  • TABLE 137. ALBANY MOLECULAR RESEARCH, INC.: PRODUCT PORTFOLIO
  • TABLE 138. ALBANY MOLECULAR RESEARCH, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. TASI GROUP: KEY EXECUTIVES
  • TABLE 140. TASI GROUP: COMPANY SNAPSHOT
  • TABLE 141. TASI GROUP: OPERATING SEGMENTS
  • TABLE 142. TASI GROUP: PRODUCT PORTFOLIO
  • TABLE 143. TASI GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. WEST PHARMACEUTICAL SERVICES, INC.: KEY EXECUTIVES
  • TABLE 145. WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT
  • TABLE 146. WEST PHARMACEUTICAL SERVICES, INC.: OPERATING SEGMENTS
  • TABLE 147. WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT PORTFOLIO
  • TABLE 148. WEST PHARMACEUTICAL SERVICES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. EDWARDS ANALYTICALS: KEY EXECUTIVES
  • TABLE 150. EDWARDS ANALYTICALS: COMPANY SNAPSHOT
  • TABLE 151. EDWARDS ANALYTICALS: OPERATING SEGMENTS
  • TABLE 152. EDWARDS ANALYTICALS: PRODUCT PORTFOLIO
  • TABLE 153. EDWARDS ANALYTICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. NSF INTERNATIONAL: KEY EXECUTIVES
  • TABLE 155. NSF INTERNATIONAL: COMPANY SNAPSHOT
  • TABLE 156. NSF INTERNATIONAL: OPERATING SEGMENTS
  • TABLE 157. NSF INTERNATIONAL: PRODUCT PORTFOLIO
  • TABLE 158. NSF INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 159. EUROFINS SCIENTIFICNELSON LABORATORIES, LLC: KEY EXECUTIVES
  • TABLE 160. EUROFINS SCIENTIFICNELSON LABORATORIES, LLC: COMPANY SNAPSHOT
  • TABLE 161. EUROFINS SCIENTIFICNELSON LABORATORIES, LLC: OPERATING SEGMENTS
  • TABLE 162. EUROFINS SCIENTIFICNELSON LABORATORIES, LLC: PRODUCT PORTFOLIO
  • TABLE 163. EUROFINS SCIENTIFICNELSON LABORATORIES, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET SEGMENTATION
  • FIGURE 2. GLOBAL PHARMACEUTICAL EQUIPMENT TESTING MARKET
  • FIGURE 3. SEGMENTATION PHARMACEUTICAL EQUIPMENT TESTING MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN PHARMACEUTICAL EQUIPMENT TESTING MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPHARMACEUTICAL EQUIPMENT TESTING MARKET
  • FIGURE 11. PHARMACEUTICAL EQUIPMENT TESTING MARKET SEGMENTATION, BY BY EQUIPMENT
  • FIGURE 12. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR GAS PERMEATION TESTER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR CONTAINER GAS PERMEABILITY TESTER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR PERMEABILITY ANALYSER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR GAS TRANSMISSION RATE INSTRUMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. PHARMACEUTICAL EQUIPMENT TESTING MARKET SEGMENTATION, BY BY SERVICE
  • FIGURE 18. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR CONTAINER TESTING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR CONTAINER CLOSURE INTEGRITY TESTING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR LIFE TESTING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR VISUAL INSPECTION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR FUNCTIONAL TESTING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR STABILITY TESTING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. PHARMACEUTICAL EQUIPMENT TESTING MARKET SEGMENTATION, BY BY END USER
  • FIGURE 27. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR GOVERNMENT ORGANIZATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 31. PHARMACEUTICAL EQUIPMENT TESTING MARKET FOR TESTING LABORATORIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 32. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 33. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 34. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 35. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 36. COMPETITIVE DASHBOARD
  • FIGURE 37. COMPETITIVE HEATMAP: PHARMACEUTICAL EQUIPMENT TESTING MARKET
  • FIGURE 38. Top player positioning, 2022
  • FIGURE 39. LABTHINK: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. LABTHINK: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. LABTHINK: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. TM ELECTRONICS, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. TM ELECTRONICS, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. TM ELECTRONICS, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. QUALITEST INTERNATIONAL, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. QUALITEST INTERNATIONAL, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. QUALITEST INTERNATIONAL, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. TEN-E PACKAGING SERVICES, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. TEN-E PACKAGING SERVICES, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. TEN-E PACKAGING SERVICES, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. ALBANY MOLECULAR RESEARCH, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. ALBANY MOLECULAR RESEARCH, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. ALBANY MOLECULAR RESEARCH, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. TASI GROUP: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. TASI GROUP: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. TASI GROUP: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. WEST PHARMACEUTICAL SERVICES, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. WEST PHARMACEUTICAL SERVICES, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. WEST PHARMACEUTICAL SERVICES, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. EDWARDS ANALYTICALS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. EDWARDS ANALYTICALS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. EDWARDS ANALYTICALS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 63. NSF INTERNATIONAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. NSF INTERNATIONAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 65. NSF INTERNATIONAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 66. EUROFINS SCIENTIFICNELSON LABORATORIES, LLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. EUROFINS SCIENTIFICNELSON LABORATORIES, LLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 68. EUROFINS SCIENTIFICNELSON LABORATORIES, LLC: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Pharmaceutical Equipment Testing Market

Start reading.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers